Table 4.
Five-year Cumulative Local Control for Group IIA – Favorable Site Tumors N = 62, median follow-up = 4.8 years (0.2 – 9.1 years)
Protocol Rate | RT Dose (Gy) | Chemotherapy | Local Failure |
---|---|---|---|
D9602 (n=62) | 36 | VA | 15%* |
IRS III (n=52) | 41.4 | VA | 11% |
IRS IV (n=43) | 41.4 | VAC/VAI/VAE | 2% |
I = ifosfamide, E = etoposide
Five of 8 failures in D9602 occurred in girls with non-bladder genitourinary primaries who did not receive RT.